Position in GRAL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$25,436,580
+$7,393,182 QoQ
Shares Held
372,588
+6.7% QoQ
Ownership
0.834%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $6,659,873,292 across 34 Diagnostics & Research names. GRAL ranks #20 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,328,836 | $1,668,945,212 | |
| 2 | DHR |
Danaher Corp /De/
|
6,925,441 | $1,319,157,998 | |
| 3 | A |
Agilent Technologies, Inc.
|
3,691,941 | $490,400,520 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
918,137 | $483,344,038 | |
| 5 | WAT |
Waters Corp /De/
|
1,032,726 | $387,313,555 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,709,161 | $330,244,084 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
223,113 | $285,029,084 | |
| 8 | ILMN |
Illumina, Inc.
|
1,429,299 | $251,313,639 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,436,580 | 372,588 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $18,043,398 | 349,137 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $29,222,733 | 341,427 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $20,132,698 | 340,482 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $17,587,489 | 342,036 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,987,301 | 156,120 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,605,188 | 145,949 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,866,652 | 135,658 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $2,194,143 | 142,755 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||